Literature DB >> 6696526

Biomechanical and biochemical properties of dog cartilage in experimentally induced osteoarthritis.

R D Altman, J Tenenbaum, L Latta, W Riskin, L N Blanco, D S Howell.   

Abstract

The finding of other investigators that increased water content is often associated with signs of a torn collagen network in human osteoarthritic (OA) cartilage led to this study. In the Pond-Nuki model of post-traumatic OA experimental but not control femoral condylar cartilage showed evidence of breakdown and stiffening of collagen network as assessed by measurement of swelling properties and indentation behaviour respectively. These changes in the unstable knees occurred despite lack of erosion of that surface cartilage ascertained from carbon black mapping and history. The stiffening rather than softening change was therefore attributed to cartilage oedema of the middle and deep certilagenous zones, wherein breakdown of collagen network has been postulated to occur. Because of insignificant reduction of total hexuronate in these cartilages, a proteoglycan (PG) profile of sedimentation coefficients for aggregate (PGA) and subunit species (PGS) was analysed to see if collagen network changes in the dog preceded PG alteration. Despite minimal histological changes our results confirmed previous findings in the tibial plateau cartilage in this model, that PGA was reduced in size and PGS increased in amount. Slight enzymatic breakdown of PGs, or altered synthesis due to cellular responses to either the injury directly or to synovial inflammation, seems necessary to explain such changes in the absence of cartilage erosion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696526      PMCID: PMC1001229          DOI: 10.1136/ard.43.1.83

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. II. Swelling.

Authors:  A Maroudas; M Venn
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

3.  The stability of bovine nasal cartilage proteoglycans during isolation and storage.

Authors:  J P Pearson; R M Mason
Journal:  Biochim Biophys Acta       Date:  1977-06-23

4.  Aggregation of cartilage proteoglycans. I. The role of hyaluronic acid.

Authors:  V C Hascall; D Heinegård
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

5.  Experimentally-induced osteoarthritis in the dog.

Authors:  M J Pond; G Nuki
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

6.  Determination os sedimentation coefficient distributions for cartilage proteoglycans.

Authors:  J C Pita; F J Muller; T Oegema; V C Hascall
Journal:  Arch Biochem Biophys       Date:  1978-02       Impact factor: 4.013

7.  Mechanical behavior of articular cartilage: quantitative changes with alteration of ionic environment.

Authors:  J R Parsons; J Black
Journal:  J Biomech       Date:  1979       Impact factor: 2.712

8.  Biphasic rheological properties of cartilage [proceedings].

Authors:  V C Mow
Journal:  Bull Hosp Joint Dis       Date:  1977-10

9.  Water content and binding in normal and osteoarthritic human cartilage.

Authors:  H J Mankin; A Z Thrasher
Journal:  J Bone Joint Surg Am       Date:  1975-01       Impact factor: 5.284

10.  Cartilage proteoglycan alterations in an experimentally induced model of rabbit osteoarthritis.

Authors:  R W Moskowitz; D S Howell; V M Goldberg; O Muniz; J C Pita
Journal:  Arthritis Rheum       Date:  1979-02
View more
  11 in total

Review 1.  Biomechanical factors in osteoarthritis.

Authors:  Farshid Guilak
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-12       Impact factor: 4.098

2.  Changes in chondrocyte gene expression following in vitro impaction of porcine articular cartilage in an impact injury model.

Authors:  Melissa S Ashwell; Michael G Gonda; Kent Gray; Christian Maltecca; Audrey T O'Nan; Joseph P Cassady; Peter L Mente
Journal:  J Orthop Res       Date:  2012-10-01       Impact factor: 3.494

3.  Computer-aided preoperative planning in knee osteotomy.

Authors:  E Y Chao; F H Sim
Journal:  Iowa Orthop J       Date:  1995

Review 4.  Animal models for osteoarthritis: processes, problems and prospects.

Authors:  K P Pritzker
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

5.  Quantification of morphometric changes in murine experimental osteoarthritis using image analysis.

Authors:  A A van Valburg; G J van Osch; P M van der Kraan; W B van den Berg
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

6.  Transient expression of the diseased phenotype of osteoarthritic chondrocytes in engineered cartilage.

Authors:  Amy M Silverstein; Aaron M Stoker; Gerard A Ateshian; J Chloe Bulinski; James L Cook; Clark T Hung
Journal:  J Orthop Res       Date:  2016-05-29       Impact factor: 3.494

7.  Proteoglycan synthesis and osteophyte formation in 'metabolically' and 'mechanically' induced murine degenerative joint disease: an in-vivo autoradiographic study.

Authors:  P M van der Kraan; E L Vitters; H M van Beuningen; W B van den Berg
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

8.  An in vivo investigation of the effect of anthraquinones on the turnover of aggrecans in spontaneous osteoarthritis in the guinea pig.

Authors:  S L Carney; C A Hicks; B Tree; R J Broadmore
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

9.  Preliminary observations of chondral abrasion in a canine model.

Authors:  R D Altman; J Kates; L E Chun; D D Dean; D Eyre
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

10.  Ex vivo pathomechanics of the canine Pond-Nuki model.

Authors:  Antonio Pozzi; Stanley E Kim; Bryan P Conrad; MaryBeth Horodyski; Scott A Banks
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.